Columbia
At Some Hospitals, Expert Panels Help Guide Anti-Amyloid Drug Decisions for Alzheimer's Patients
Premium
These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such programs are necessary.
Foresight Diagnostics Launches Lymphoma Personalized Treatment Clinical Trial
The trial will study the use of Foresight's Clarity MRD assay in identifying early treatment responders for therapy de-escalation.
Columbia University Leads Project Studying Impact of Genetics, Environment on Drug Responses
Researchers plan to commercialize technology generated through this work, which has a $39.5 million grant from the Advanced Research Projects Agency for Health.
Regeneron Gene Therapy Restores Hearing in Infant With Genetic Form of Deafness, Data at ASGCT Show
Premium
The 10-month-old patient was treated with DB-OTO, a gene therapy developed by Decibel Therapeutics, which Regeneron acquired last year.
Nonprofit organizations are developing personalized therapies for forms of ALS too rare to attract the attention of larger drug developers.